Statement: no cardiac or bowel-related adverse events were recorded in the primary trial. gain of chromosome 2p is a cytogenetic abnormality that refers to the duplication of all or part of the short arm of chromosome 2.
Primary_evidence: Adverse Events 1:   Total: 2/30 (6.67%)   Dry Eyes  [1]1/30 (3.33%)   Diarrhea  [2]1/30 (3.33%)